In last trading session, Sunshine Biopharma Inc (NASDAQ:SBFM) saw 3.95 million shares changing hands with its beta currently measuring -0.96. Company’s recent per share price
Sunshine Biopharma Inc (NASDAQ:SBFM) has a beta value of -0.97 and has seen 1.51 million shares traded in the last trading session. The company, currently
During the last session, Sunshine Biopharma Inc (NASDAQ:SBFM)’s traded shares were 1.36 million, with the beta value of the company hitting -0.97. The 52-week high
Sunshine Biopharma Inc (NASDAQ:SBFM)’s traded shares stood at 1.7 million during the last session, with the company’s beta value hitting -0.99. At the close of
Sunshine Biopharma Inc (NASDAQ:SBFM)’s traded shares stood at 8.44 million during the last session, with the company’s beta value hitting -1.00. At the close of
In last trading session, Sunshine Biopharma Inc (NASDAQ:SBFM) saw 3.65 million shares changing hands with its beta currently measuring -0.93. Company’s recent per share price
Sunshine Biopharma Inc (NASDAQ:SBFM) has a beta value of -0.92 and has seen 2.19 million shares traded in the last trading session. The company, currently
Sunshine Biopharma Inc (NASDAQ:SBFM) has a beta value of -0.91 and has seen 5.16 million shares traded in the last trading session. The company, currently
Sunshine Biopharma Inc (NASDAQ:SBFM) has a beta value of -0.91 and has seen 2.57 million shares traded in the last trading session. The company, currently
During the last session, Sunshine Biopharma Inc (NASDAQ:SBFM)’s traded shares were 2.01 million, with the beta value of the company hitting -0.89. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
